Absci Corporation - Common Stock Aktie - Unternehmensdaten & Kurse - US00091E1091 | MoneyPeak

Absci Corporation - Common Stock

Share · US00091E1091 · ABSI (XNAS)

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

0

9

1

2

0

No Price

20.12.2025 00:52

Current Prices from Absci Corporation - Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	ABSI	USD	20.12.2025 00:52	3,45 USD	0,07 USD +2,07 %

Share Float & Liquidity

Free Float 88,27 %

Shares Float 132,73 M

Shares Outstanding 150,37 M

Company Profile for Absci Corporation - Common Stock Share

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Get up to date insights from finAgent about Absci Corporation - Common Stock

Company Data

Name Absci Corporation - Common Stock

Company Absci Corporation

Symbol ABSI

Website https://www.absci.com

Primary Exchange

NASDAQ

ISIN US00091E1091

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Sean McClain

Market Capitalization 508 Mio

Country United States of America

Currency USD

Employees 0,2 T

Address 18105 SE Mill Plain Boulevard, 98683 Vancouver

IPO Date 2021-07-22

Ticker Symbols

Name	Symbol
NASDAQ	ABSI

More Shares

Investors who hold Absci Corporation - Common Stock also have the following shares in their portfolio:

OAKTREE ACQUISITION CORP II CLASS A Share

Y-MABS THERAPEUTICSCS INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025